Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.37 |
| ▸ | PRKCG | P05129 | 3/20 | 0.37 |
| ▸ | PRKCB | P05771 | 3/20 | 0.37 |
| ▸ | PRKCA | P17252 | 3/20 | 0.37 |
| ▸ | PRKCH | P24723 | 3/20 | 0.37 |
| ▸ | PRKCI | P41743 | 3/20 | 0.37 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.37 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.37 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.37 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.36 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.36 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11557138 | 0.98 | OPRM1 (0.36) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL30915579 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL20459264 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL28995099 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL18165672 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL13069532 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL17676329 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL13464149 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL14520047 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL28820257 | 0.89 | TSHR (0.44) | ZDHHC7PRKD3PRKCGPRKCBPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7994154-B2 | Substituted liposaccharides useful in the treatment and prevention of endotoxemia | Ersai R&D Management Co., Ltd. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20100227835-A1 | SUBSTITUTED LIPOSACCHARIDES USEFUL IN THE TREATMENT AND PREVENTION OF ENDOTOXEMIA | EISAI R&D MANAGEMENT CO., LTD (JP) | 2010-09-09 | — | — | US | disclosed |
| US-7737129-B2 | Substituted liposaccharides useful in the treatment and prevention of endotoxemia | EISAI R & D MANAGEMENT CO., LTD. (JP) | 2010-06-15 | — | — | US | disclosed |
| US-20080214802-A1 | Substituted Liposaccharides Useful in the Treatment and Prevention of Endotoxemia | EISAI CO., LTD. (JP) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214802-A1 | Substituted Liposaccharides Useful in the Treatment and Prevention of Endotoxemia | LIPG, FUT6, UGCG | ZDHHC7 1271/4885PRKD3 3221/4885PRKCG 2702/4885 |
| US-20100227835-A1 | SUBSTITUTED LIPOSACCHARIDES USEFUL IN THE TREATMENT AND PREVENTION OF ENDOTOXEMIA | LIPG, FUT6, UGCG | ZDHHC7 1271/4885PRKD3 3221/4885PRKCG 2702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.